Literature DB >> 1618216

Pleural effusion following coronary perforation during balloon angioplasty: an unusual presentation of the postpericardiotomy syndrome.

J Escaned1, R A Ahmad, M F Shiu.   

Abstract

We report on the development of features of the postpericardiotomy syndrome following coronary perforation during balloon angioplasty, in a patient that was managed conservatively. The case illustrates that while cardiac tamponade does not invariably follow coronary perforation, late consequences derived from this complication may occur. It also widens the spectrum of conditions where the postpericardiotomy syndrome has been observed.

Entities:  

Mesh:

Year:  1992        PMID: 1618216     DOI: 10.1093/oxfordjournals.eurheartj.a060241

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

1.  Postpericardiotomy syndrome after cardiac surgery.

Authors:  Joonas Lehto; Tuomas Kiviniemi
Journal:  Ann Med       Date:  2020-05-02       Impact factor: 4.709

2.  Postcardiac injury syndrome after percutaneous coronary intervention.

Authors:  Jin-Seok Park; Dae-Hyeok Kim; Woong-Gil Choi; Seoung-Il Woo; Jun Kwan; Keum-Soo Park; Woo-Hyung Lee; Jung-Jin Lee; Yong-Jun Choi
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

3.  Postcardiac injury syndrome following radiofrequency ablation of idiopathic left ventricular tachycardia.

Authors:  Liang Rong Zheng; Xiaosheng Hu; Shudong Xia; Yao Chen
Journal:  J Interv Card Electrophysiol       Date:  2007-04-21       Impact factor: 1.900

4.  A presentation of postcardiac injury syndrome after successful chronic total occlusion percutaneous coronary intervention using dissection re-entry techniques.

Authors:  Gabby Elbaz-Greener; Harindra C Wijeysundera
Journal:  Clin Case Rep       Date:  2017-04-18

5.  Acute Pericarditis after Percutaneous Coronary Intervention: A Case Report.

Authors:  Greta Rodevič; Povilas Budrys; Giedrius Davidavičius
Journal:  Medicina (Kaunas)       Date:  2021-05-13       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.